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Summary: Intefläboratory Variation of the meäsurement of 25fhydrpxy vitamin D, 24,25-dihydroxy vitamin D and
1,25-dihydroxy vitamin D by six labPratories in the Netherlands was studied. Three different serum samples and
two different Standard Solutions of each metabolite were assayed. Sübstantial interlaboratory Variation was found
for the meäsurement of serum samples. The mean interlaboratory CV's for the 25-hydrpxy vitamin D, 24,25-di-
hydroxy vitamin D and 1,25-dihydroxy vitamin D ässays in the three sera were 48%, 38% and 20% respectively. The
meäsurement of Standard Solutions of all metabolites showed relative little Variation (mean CV 8%). The small
number of samples allowed no evaluätion of intralaboratory Variation. The müch higher CV's of the measurements
of serum samples, when cpmpared to Standard Solutions, may be attributed to differences in extraction and purifica-
tion proeedures which äre probäbly responsible for the presence of varying ampunts pf interfering substances during
the final quantificätion of metabolites.
Ringversuch zur Bestimmung von Vitamin D-MetaboUten
Zusammenfassung: In einem Ringversuch wurde die Bestimmung der 25-Hydroxy-, 24,25-Dihydroxy- und 1,25-Di-
hydrpxy-Metabolite von Vitamin D in 6 Laboratorien der Niederlande überprüft. Drei verschiedene Serumproben
und zwei verschiedene Standardlösungeri jedes Metaboliteri wurden untersucht. Für die Bestimmung in Serumproben
wurden erhebliche Unterschiede zwischen den Laboratorien festgestellt. Die mittleren Variationskoeffizienten
zwischen den Laboratorien für die Bestimmung der 25-Hydroxy-, 24,25-Dihydroxy- und 1,25-Dihydroxy-Metaboli-
ten von Vitamin D in den drei Seren betrugen 48%, 38% und 28%. Die Bestimmung in den Standardlösungen aller
The term vitamin D includes both Da and 1)3 derivatives. However, vitamin D2 metabolite concentrations are assumed to be
negligible.
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Metaboliten zeigte einen relativ geringen Variationskoeffizienten von im Mittel 8%. Die geringe Zahl der Proben
erlaubte keine Auswertung der Variation innerhalb der einzelnen Laboratorien. Verglichen mit der Bestimmung in Stan-
dardlösungen beruhen die sehr viel höheren Variationskoeffizienten der Messung von Serumproben wahrscheinlich
auf Unterschieden in Extraktions- und Reinigungsverfahren, die möglicherweise verantwortlich sind für die Anwesen-
heit unterschiedlicher Mengen störender Substanzen während der abschließenden Quantifizierung der Metabolite.
Introduction
In the past decade clinical investigations related to
vitamin D metabolism have resulted in a rapidly growing
amount of data on vitamin D metabolite concentrations
in human blood, both in healthy subjects and in sub-
jects suffering from various diseases influencing vitamin
D metabolism (l, 2, 3). The methods in use for the
measurement of plasma and serum concentrations of
vitamin D metabolites have recently been reviewed by
Seamark and coworkers (4). Reference intervals repörted
in this paper for the main vitamin D metabolites
25-hydroxy vitamin D, 24R,25-dihydroxy vitamin D
and la,25-dihydroxy vitamin D vary considerably.
A possible cause for this Variation may be the fact that
vitamin D metabolism is regulated by exposüre to sun-
shine, dietary intake and various parameters of calcium
and phosphate metabolism, all factors that vary sub-
stantially between different pppulations. Moreover,
recent research has revealed that some of the earlier
assay methods produced erroneous values because of
lack of specificity (S). To what extent however, different
reference intervals are caused by either racial and
environmental factors or by different assay procedures
remains unclear. In order to investigate comparability
of results obtained with different assay procedures a
collaborative study on the measurement of 25-hydroxy
vitamin D, 24R,25-dihydroxy vitamin D and la,25-di-
hydroxy vitamin D was carried out by six laboratories in
the Netherlands.
Materials and Methods
Vitamin D metabolites
25-hydroxy vitamin D3 was obtained from Duphar, Weesp, The
Netherlands. 24R,25-dihydroxy vitamin Dß and l<*,25-dihydroxy
vitamin D3 were kindly donated by Hoffmann-LaRöche, Basle,
Switzerland. Purity of vitamin D metabolites was verified by
straight phase HPLC on a Nucleosil 10-NO2 columri developed in
n-hexane/isopropanol/water (90 + 10 + 0.35 by volume) at a
flow rate of 2 ml/min.
Sample s
Serum was collected from healthy subjects and pooled.
From this pool three sera were prepared: A, B and C.
Serum A was prepared by diluting a portion of the pool with a
solution of 50 g/l human serum albumin, fatty acid free in 9 g/l
sodium Chloride to 0.73 times the original concentration.
Serum B was prepared by addition of 25-hydroxy vitamin D3,
24 R,25-dihydroxy vitamin D3 and la,25-dihydroxy vitamin D3
to a part of the pool.
Serum C was the pool without modification.
The three sera were divided into 5 ml-aliquots and stoied at
-40°C.
Two Standard Solutions of each metabolite were prepared in
ethanol and stored at - 20 °C. All six Standard Solutions were
in the concentratiori ränge customarily used by most laboratories.
Assay methods
A brief survey of the assay techniques used by the different
laboratories is given in table 1. All laboratories measured
25ihydroxy vitamin D, five measured 24k,25-dihydroxy vita-
min D and four la,25-dihydroxy vitamin i). Serum A, B arid C
were measured iri düplicate by each labpratory. Sera äs well äs
ethanolic Solutions were assayed according to the Standard
procedure of eaeh participank
Results
The results of the measurements of serum samples arid
Standard Solutions are shown in table 2 A—C. For each
metabolite the CV's for the Standard Solutions were
small when corripared to the CV's for the serum samples.
The highest interlaboratory CV was observed for the
25-hydroxy vitamin D assays, whereas the la,25-di-
hydroxy vitamin D assays showed the lowest CV. With
regard to the 25-hydroxy vitamin D assays the high
CV's for the serum samples were mainly caused by the
very high and very low values for all three samples found
by laboratory b and d, respectively. This relative devia-
tion in the measurements of both laboratories was not
seen for the Standard Solutions of 25-hydroxy Vitamin D.
The Variation for both the 24R,25-dihydtoxy vitamin D
and the la,25-dihydroxy vitamin D assays seemed to be
more at random. The only outstanäing fact was again
the relatively low values fpr the serum samples measured
by laboratory d (except the la,25-dihydroxy vitamin D
concentration in serum A). When the ratios of the serum
concentrations found in A and C, and in B and C are
cqmpared (tab. 3), it can be seen that the values measured
for A/C with the 25-hydroxy vitamin D assays are
strikingly close, despite the very high interläboratory
CV for these assays. Considerably more Variation in the
measured ratios was found with the 24R,25-dihydroxy
vitamin D and la,25-dihydrqxy vitamin D assays.
With regard to intralabqratqry CV's the number of.meas-
urements was too small to allow a reliable assessment of
this Variation. In addition, each laboratory used its own
Standard procedure for the measuremerit of serum
samples, which means that the number of individual
competitive protein binding, RIA or UV determinations
for a single serum sample varied frqrn l to 3. In general
however, the intralaboratory CV's of all individual meas-
urements for serum A, B and C were less than 20% for
each metabolite. The intralaborätpry CV's fqr the Stand-
ard Solutions derived from the individual competitive
protein binding, RIA ör UV measurements were less than
10% (number qf measurements varied frorri l to 4).
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Tab. i. Assay techniques
CPB = competitive protein binding DBF = vitamin D binding protein
Lab
a
b
c
d
e
Extraction
solvent*)
Ether
Methanol/
ether
Methylene-
chloride/
methanol/water
Ethyl acetate/
cyclohexane
and ethyl
acetate/cyclo-
hexane/
methanol
n-Hexane/
isopropanol/
n-butanol
25-hydroxy vitamin D
Purification Quantification
Sephadex
LH-20
Open silicic
acid column
—
Straight phase
HPLC
Straight phase
HPLC
Reversed phase
HPLC
CPB with
serum DBP
CPB with
serum DBP
CPB with
serum DBP
CPB with
serum DBP
24 R,25-dihydroxy vitamin D
Purification Quantification
Open silicic
acid column
Straight phase
HPLC
Straight phase
HPLC
Straight phase
HPLC
CPB with
serum DPB
CPB with
serum DBP
CPB with
serum DBP
CPB with
serum DBP
la,25-dihydroxy vitamin D
Purification Quantification
Sephadex
LH-20,
Straight phase
HPLC
-
Straight phase
HPLC
Straight phase
HPLC
CPB with
duodenal
receptor
-
RIA
CPB with
duodenal
receptor
f Ether Sephadex
LH-20
CPB with
serum DBP
Sephadex
LH^O,
Straight phase
HPLC
CPB with
serum DBP
Sephadex
LH-20,
Straight phase
HPLC
RIA
*) for all three metabolites
Tab. 2A. Results of 25-hydroxy vitamin D measurements in
nmol/1.
Lab
a
b
c
d
e
f
Mean:
SD:
CV:
Serum
A
38
82
44
19
32
34
41
21
52
B
68
138
81
38
61
64
75
34
45
C
51
110
58
33
45
46
57
27
47
Standard solution
1 2
150
172
153
139
140
146
150
1?
8
260
267
283
229
230
258
225
21
8(%)
Tab. 2 B. Results of 24R,25i4ihydroxy vitamin D ineasurements
in nmol/1.
Lab
a
b
c
d
e
f
Mean:
SD:
CV:
Serum
A B
1.7
3.4
0.9
3.1
1.8
2.2
1.0
48
8.4
8.5
3.0
9.9
7.2
7.4
2.6
36
C
_
3.1
3.5
1.5
3.8
2.6
2.9
0.9
31
Standard solution
3 4
_
61
68
68
55
18*)
63
6
10
78
90
82
67
23*)
79
10
12 (%)
Discussion
As far äs we know no interlaboratory comparison of the
measurement of vitamin D metabolites has been described
in the literatüre until now. The results from this study
reveal that only small differences exist with regard to
quantification methods used in the laboratories. The
interlaboratory CV's fof the ethanolic Solutions were
well within the ränge of intralaboratory CV's that are
usual with competitive protein binding assays for vita-
min D metabolites. The measurement of serum samples
however resulted in substantially more Variation. Ob-
viously these high CV's originate from extraction and
Tab. 2C. Results pf -25-dihydroxy vitamin D measurements
in pmol/1.
Lab
a
b
c
d
e
f
Mean:
SD:
CV:
Serum
A
57
—
_
65
66
82
67
11
16
B
152
-
—80
160
171
141
41
29
C
119
-
^
81
96
98
98
15
16
Standard solution*)
5 6
2.31
—
—2.36
2.24
2.49
2.35
0.11
4
3.61
—
—3.64
3.61
4.05
3.73
0.22
6(%)
*) Not used for calculation of mean, SD and CV *) Concentrations of Standard Solutions in nmol/1
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Tab. 3 A. Concentration in serum A/concentration in serum C.
Lab.
a
b
c
d
e
f
25-hydroxy
vitamin D
0.74
0.74
0.75
0.57
0.72
0.74
24R,25-
dihydroxy
vitamin D
0.55
0.97
0.62
0.80
0.69
la,25-dihydroxy
vitamin D
0.48
0.80
0.69
0.84
Tab. 3 B. Concentration in serum B/concentration in serum C.
Lab.
a
b
c
d
e
f
25-hydroxy
vitamin D
1.34
1.25
1.40
1.12
1.37
1.39
24R,25-
dihydroxy
vitamin D
2.71
2.43
1.99
2.60
2.77
la,25-dihydroxy
vitamin D
1.28
0.99
1.68
1.74
v
purification procedures in use for the serum samples.
For all assays (except the 25-hydroxy vitamin D assay
of laboratory ä) competitive protein binding was used
for quantification of metabolites. The receptpr protein
for the 25-hydroxy vitamin D and 24R,25-dihydroxy
vitamin D assays was in all cases the serum vitamin D
binding protein. This protein however, possesses high
affinity for several vitamin D metabolites (including
vitamin D2 metabolites) and in addition it is sensitive to
other interfering substances in serum extracts (5).
Furthermore the vitamin D metabolites with high affinity
for the vitamin D binding protein migrate close together
in most Chromatographie Systems, which makes a com-
plete Separation difficult to achieve. The use of different
extraction solvents and different purification procedures
may therefore result in the presence of different non-
specific and specific (other vitamin D metabolites) inter-
fering contaminants during the final quantification
procedure. This may, at least in part, explain the high
interlaboratory CV's for both the 25-hydroxy vitamin D
and 24R,25-dihydroxy vitamin D assays. It is unlikely
however that this Variation was caused by vitamin D?
metabolites, because food in the Netherlands is not
fortified with vitamin D2. This was confirmed by
analysis of another serum pool of 20 healthy subjects,
where displacement was only found in fractions cor-
responding to vitamin D3 metabolites (6).
With regard to the la,25-dihydroxy vitamin D assays
two competitive protein binding procedures based on
the ducken duodenal la,25-dihydroxy Vitamin D
receptor, and two RIA procedures were used for
quantification. The duodenal receptor offers the
advantage of high specificity for lä^S-dihydröxy
vitamin D (7). So far no other Vitamin D metabolite
has been described that possesses equally high affinity
for this receptor. Data on the cross-reactivity of the
antibodies used for the RIA procedures show that they
are less specific than the duodenal receptor (8, 9).
la,25-dihydröxy vitamin D can however relatively
easily be sepaiated from interfering substances by
Chromatographie methods. As ä result, böth the higher
specificity of the binding pröteins and the relatively
easy purification of la,25-dihydroxy vitamin' D lead to
higher overall specificity for the la,25-dihydrpxy vita-
min D assays. This was confirmed by the relatively low
interlaboratory CVs.
In conclusion, the quantification methods per se showed
good reproducibility iii this study. The measufement of
serum satnples however revealed high interlaboratory
CV's, especially for the 254iydroxy vitamin D and
24R,25-dihydroxy vitamin D assays, which are prpbably
due to different extraction and purification procedures.
Standardization of these proeedures or improvement öf
the specificity of binding pröteins may resiilt in better
interlaböratöfy precision. Moreover refeirerice Standards
and reference sera shpuld enable a continupus evaluätion
and comparison of assäy procedufes. At the present
time interlaboratoiiy Variation seems to be too high
for a comparison of values from different laboratories
withput due consideratipnj especially with regard to
concentrations of 25-hydroxy Vitamin D and 24R,25-di-
hydröxy Vitamin D. Besides, in coüntries were food is
fortified with Vitamin D2, interlaboratory Variation ihay
be even larger, owing to the different properties pf
vitamin D2 metabolites with regard to Chromatographie
mobility and affinity for the binding pröteins in use (10).
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